Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biomedic Medical Group appears to be an active China-focused medical technology and medical device company rather than a therapeutics biotech or pharmaceutical developer. Public descriptions characterize it as an international medical technology enterprise focused on interventional and radiotherapy products, with additional coverage across radiology, ultrasound diagnosis, surgical, and interventional consumables. The group seems to operate through Hong Kong and mainland China entities, including Shengyuan Medical Technology (Hong Kong) Co., Ltd. and Guangzhou Shengyuan Medical Technology Co., Ltd. Available evidence suggests its business model centers on commercialization, distribution, and product supply in minimally invasive oncology, vascular intervention, radiotherapy, imaging, and related hospital-use device categories. It has also been identified as RTsafe's exclusive distributor in China for certain radiotherapy-related products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biomedic Medical Group.